Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin
Isbrucker RA , Burdock GA . Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin . Regul Toxicol Pharmacol 2006 ; 46 : 167-192.
In vivo 11 - HSD- 2 activity: Variability, salt-sensitivity, and effect of licorice
Ferrari P , Sansonnens A , Dick B et al. In vivo 11 - HSD- 2 activity: variability, salt-sensitivity, and effect of licorice . Hypertension 2001 ; 38 : 1330-1336.
Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor
Arriza JL , Weinberger C , Cerelli G et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor . Science 1987 ; 237 : 268-275.
Farese S , Kruse A , Pasch A et al. Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients . Kidney Int 2009 ; 76 : 877-884.
Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: Effects of 11 - Hydroxysteroid dehydrogenase inactivation
Young MJ , Moussa L , Dilley R et al. Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 - hydroxysteroid dehydrogenase inactivation . Endocrinology 2003 ; 144 : 1121-1125.
Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart
Wilson P , Morgan J , Funder JW et al. Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart . Clin Sci (Lond) 2009 ; 116 : 731-739.
11 -hydroxysteroid dehydrogenase type II inhibition causes cerebrovascular remodeling and increases infarct size after cerebral ischemia
Osmond JM , Dorrance AM . 11 -hydroxysteroid dehydrogenase type II inhibition causes cerebrovascular remodeling and increases infarct size after cerebral ischemia . Endocrinology 2009 ; 150 : 713-719.